News

Here’s how much money Paige Bueckers and the other WNBA draft picks will earn
It’s time for WNBA players to get a higher percentage of the league’s basketball-related income,’ former player Chiney ...
Trump gave tech companies a break from tariffs. Here’s how long that could last.
Tech companies got a break from President Donald Trump’s tariffs — but for how long?
Star Entertainment 1H Statutory Net Loss A$301.9 Mln
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Nvidia’s latest move could be a bid to escape new tariffs
Nvidia will make AI supercomputers in the U.S. Is the company trying to win favor with the Trump administration ahead of new ...
'Yield curve tsunami' means a painful rise in U.S. government's cost of capital
It was last week's surge in long-term Treasury yields -- the rate on the 30-year T-bond saw its biggest weekly jump since ...
S&P 500 intraday volatility hits highest level since 2008: Cboe
Last week's wild trading action featured some stunning intraday reversals. For example, on Wednesday, the S&P 500 opened ...
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
The S&P 500 reached an ominous-sounding milestone on Monday, even as stocks largely added to their gains from last week’s ...
I’m 81 with $240K in mutual funds, no debt and living in a condo I’ve fully paid for. But am I ready for a major financial downturn?
Have an issue with your financial adviser or looking for a new one? Email questions or concerns to [email protected].
MicroStrategy reverts to selling just common stock to buy bitcoin
The company, doing business as Strategy, sold nearly one million of its shares to the public so it could use the money to buy ...
Trump tariff uncertainty, bad weather loom over railroads. Here’s why that matters.
Earnings for railroad operators kick off this week when CSX Corp. reports first-quarter results after market close Wednesday, ...
Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
As ‘sell America’ trade rattles Washington and Wall Street, here’s what could bring U.S. markets back from the brink
President Trump’s decision to pause some of his tariffs helped spur a rebound in stocks last week. But it didn’t stop the ...